Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arunjyoti Bio Ventures Ltd submitted its Annual Secretarial Compliance Report for FY 2024-25, reviewed by Vivek Surana & Associates. The company was largely compliant with SEBI LODR Regulations, but two minor lapses were noted: (1) late payment of annual listing fees to BSE, for which the company paid Rs. 7,670 along with interest on 08.06.2024, and (2) late submission of shareholding pattern (SHP), for which it paid a penalty of Rs. 18,000 plus GST after filing on 01.05.2024. All other compliance areas — including secretarial standards, board policies, website disclosures, director eligibility, related party transactions, insider trading, and performance evaluation — were marked as compliant. The company has no subsidiaries, and there was no change in statutory auditors during the year.
Minor administrative compliance lapses already rectified with penalties paid; no major governance red flags. Unlikely to have material impact on the stock price, but signals weak internal compliance monitoring.